Joseph L. Kelley

6.2k total citations
129 papers, 3.0k citations indexed

About

Joseph L. Kelley is a scholar working on Obstetrics and Gynecology, Reproductive Medicine and Surgery. According to data from OpenAlex, Joseph L. Kelley has authored 129 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 61 papers in Obstetrics and Gynecology, 60 papers in Reproductive Medicine and 43 papers in Surgery. Recurrent topics in Joseph L. Kelley's work include Endometrial and Cervical Cancer Treatments (58 papers), Ovarian cancer diagnosis and treatment (53 papers) and Colorectal and Anal Carcinomas (18 papers). Joseph L. Kelley is often cited by papers focused on Endometrial and Cervical Cancer Treatments (58 papers), Ovarian cancer diagnosis and treatment (53 papers) and Colorectal and Anal Carcinomas (18 papers). Joseph L. Kelley collaborates with scholars based in United States, United Kingdom and Ireland. Joseph L. Kelley's co-authors include Robert P. Edwards, Paniti Sukumvanich, Sushil Beriwal, John T. Comerci, Alexander Olawaiye, Hayeon Kim, Thomas C. Krivak, Dwight E. Heron, Kristina Gerszten and Madeleine Courtney‐Brooks and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Joseph L. Kelley

122 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joseph L. Kelley United States	33	1.7k	1.1k	987	625	518	129	3.0k
Christine H. Holschneider United States	25	1.4k 0.8×	1.5k 1.4×	1.0k 1.1×	488 0.8×	605 1.2×	67	3.0k
Lisa M. Landrum United States	24	1.4k 0.8×	1.1k 1.0×	710 0.7×	561 0.9×	829 1.6×	87	2.9k
Allan Covens Canada	37	2.6k 1.5×	2.2k 2.1×	1.0k 1.0×	1.2k 1.9×	807 1.6×	141	4.1k
Damienne Castaigne France	36	1.7k 1.0×	2.2k 2.0×	1.1k 1.1×	409 0.7×	558 1.1×	110	3.4k
Floor Backes United States	32	1.7k 1.0×	1.6k 1.5×	648 0.7×	461 0.7×	895 1.7×	179	3.4k
J. S. Berek United States	21	1.1k 0.6×	1.2k 1.1×	1.3k 1.3×	900 1.4×	518 1.0×	48	2.7k
Alexander Olawaiye United States	32	3.0k 1.7×	2.3k 2.1×	1.4k 1.4×	1.1k 1.8×	911 1.8×	146	4.8k
David M. Boruta United States	28	1.9k 1.1×	1.6k 1.5×	727 0.7×	385 0.6×	419 0.8×	77	2.7k
Arlan F. Fuller United States	35	1.9k 1.1×	2.3k 2.1×	939 1.0×	494 0.8×	708 1.4×	91	4.0k
U. Beller Israel	20	2.7k 1.5×	2.6k 2.4×	1.1k 1.1×	893 1.4×	824 1.6×	57	4.6k

Countries citing papers authored by Joseph L. Kelley

Since Specialization

Citations

This map shows the geographic impact of Joseph L. Kelley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph L. Kelley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph L. Kelley more than expected).

Fields of papers citing papers by Joseph L. Kelley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph L. Kelley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph L. Kelley. The network helps show where Joseph L. Kelley may publish in the future.

Co-authorship network of co-authors of Joseph L. Kelley

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph L. Kelley. A scholar is included among the top collaborators of Joseph L. Kelley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph L. Kelley. Joseph L. Kelley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ross, Malcolm S., Esther Elishaev, Jessica Berger, Joseph L. Kelley, & Sarah E. Taylor. (2018). Prognostic Significance of omental Disease and the Role of Omental Sampling in Patients With Uterine Carcinosarcoma. International Journal of Gynecological Cancer. 28(2). 254–259. 12 indexed citations

Dohopolski, Michael, Zachary D. Horne, Dinesh Pradhan, et al.. (2018). The Prognostic Significance of p16 Status in Patients With Vulvar Cancer Treated With Vulvectomy and Adjuvant Radiation. International Journal of Radiation Oncology*Biology*Physics. 103(1). 152–160. 16 indexed citations

Orr, Brian & Joseph L. Kelley. (2016). Benign Breast Diseases: Evaluation and Management. Clinical Obstetrics & Gynecology. 59(4). 710–726. 21 indexed citations

Lefkowits, Carolyn, Chelsea Chandler, Paniti Sukumvanich, et al.. (2016). Validation of the 'surprise question' in gynecologic oncology: comparing physicians, advanced practice providers, and nurses. Gynecologic Oncology. 141. 128–128. 6 indexed citations

Yu, Miao, R. Marshall Austin, Jeff Lin, et al.. (2015). The Role of High-Risk Human Papilloma Virus Testing in the Surveillance of Cervical Cancer After Treatment. Archives of Pathology & Laboratory Medicine. 139(11). 1437–1440. 10 indexed citations

Lin, Jeff, Malolan S. Rajagopalan, Paniti Sukumvanich, et al.. (2014). Impact of Adjuvant Chemotherapy With Radiation for Node-Positive Vulvar Cancer: A National Cancer Data Base (NCDB) Study. International Journal of Radiation Oncology*Biology*Physics. 90(1). S112–S112. 1 indexed citations

Gill, Beant S., Hayeon Kim, Christopher J. Houser, et al.. (2014). Extended Clinical Outcomes of 3D High-Dose-Rate Intracavitary Brachytherapy with MRI-Based Planning for Treatment of Cervical Cancer. Brachytherapy. 13. S33–S33. 2 indexed citations

Rajagopalan, Malolan S., Karen M. Xu, Jeff Lin, et al.. (2014). Patterns of care and brachytherapy boost utilization for vaginal cancer in the United States. Practical Radiation Oncology. 5(1). 56–61. 18 indexed citations

Hinshaw, Hilary D., Bunja Rungruang, Joseph L. Kelley, et al.. (2013). The Risk of Subsequent Malignancies in Women With Uterine Papillary Serous or Clear Cell Endometrial Cancers. International Journal of Gynecological Cancer. 23(6). 1044–1049. 8 indexed citations

10.

Gold, Michael A., William E. Brady, Heather A. Lankes, et al.. (2012). A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: A Gynecologic Oncology Group study. Gynecologic Oncology. 125(3). 635–639. 41 indexed citations

11.

Osborne, Raymond, Virginia L. Filiaci, Julian C. Schink, et al.. (2011). Phase III Trial of Weekly Methotrexate or Pulsed Dactinomycin for Low-Risk Gestational Trophoblastic Neoplasia: A Gynecologic Oncology Group Study. Journal of Clinical Oncology. 29(7). 825–831. 110 indexed citations

12.

Kanbour‐Shakir, Amal, Marguerite Bonaventura, Umut Özbek, et al.. (2011). Rationale of Excisional Biopsy After the Diagnosis of Benign Radial Scar on Core Biopsy. American Journal of Clinical Oncology. 36(1). 7–11. 38 indexed citations

13.

Olawaiye, Alexander, Kristin K. Zorn, Robert P. Edwards, et al.. (2011). Preoperative high dose rate brachytherapy for clinical stage II endometrial carcinoma. SHILAP Revista de lepidopterología. 1 indexed citations

14.

Shukla, Gaurav, Sushil Beriwal, Thomas C. Krivak, et al.. (2011). Clinical Investigations Preoperative high dose rate brachytherapy for clinical stage II endometrial carcinoma. Journal of Contemporary Brachytherapy. 2(2). 70–73. 6 indexed citations

15.

Vlad, Anda, Raluca A. Budiu, Diana Lenzner, et al.. (2009). A phase II trial of intraperitoneal interleukin-2 in patients with platinum-resistant or platinum-refractory ovarian cancer. Cancer Immunology Immunotherapy. 59(2). 293–301. 54 indexed citations

16.

Beriwal, Sushil, et al.. (2008). High-dose rate brachytherapy (HDRB) for primary or recurrent cancer in the vagina. Radiation Oncology. 3(1). 7–7. 32 indexed citations

17.

Guirguis, Alfred, Amal Kanbour‐Shakir, & Joseph L. Kelley. (2007). Epithelioid Angiosarcoma of the Mons After Chemoradiation for Vulvar Cancer. International Journal of Gynecological Pathology. 26(3). 265–268. 10 indexed citations

18.

Chivukula, Mamatha, Jennifer L. Hunt, Gloria Carter, et al.. (2006). Recurrent Gynandroblastoma of Ovary-A Case Report. International Journal of Gynecological Pathology. 26(1). 30–33. 16 indexed citations

19.

Kelley, Joseph L., et al.. (1998). Comparing PPI energy indexes to alternative data sources. Monthly labor review. 121(12). 33–41. 4 indexed citations

20.

Kelley, Joseph L., Gregory J. Naus, & Wayne A. Christopherson. (1991). Endodermal sinus tumor of the ovary: A case series with flow cytometric DNA content analysis. Gynecologic Oncology. 42(1). 34–38. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact